Table 2.
In vivo silver intake over 7-day study duration for ME dressing (negative control) and ROCF-ciNPT dressing
Sample | Silver (μg/g) |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Standard of care (ME dressing) |
ROCF-ciNPT |
|||||||||
Day 0 | Day 1 | Day 3 | Day 5 | Day 7 | Day 0 | Day 1 | Day 3 | Day 5 | Day 7 | |
Feces | <0.2 | <0.2 | <0.2 | <0.2 | <0.2 | <0.2 | <0.2 | <0.2 | <0.2 | <0.2 |
Urine | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 |
Blood | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 |
Kidney | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 |
Liver | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 |